Herantis Pharma Oyj engages in the research and development of biopharmaceutical products. It offers medicinal products such as Cis-UCA eye drops for dry eye, CDNF for Parkinson's disease, Lymfactin for secondary lymphedema, Cis-UCA emulsion cream for atopic dermatitis, and CDNF for amyotrophic lateral sclerosis (ALS). The company was founded by Eero Hemminki Castren, Henri Juhani Huttunen, Heikki Rauvala, and Mart Saarma in 2008 and is headquartered in Espoo, Finland.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
11
Frequently Asked Questions
What is Market Cap of Herantis Pharma OYJ?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Herantis Pharma OYJ market cap is $59.47M.
What is the 52-week high for Herantis Pharma OYJ?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Herantis Pharma OYJ 52 week high is $3.51 as of September 06, 2025.
What is the 52-week low for Herantis Pharma OYJ?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Herantis Pharma OYJ 52 week low is $3.51 as of September 06, 2025.
What is Herantis Pharma OYJ stock price today?
Herantis Pharma OYJ stock price today is $3.51.
What was Herantis Pharma OYJ stock price yesterday?
Herantis Pharma OYJ stock price yesterday was $3.51.
What is the PE ratio of Herantis Pharma OYJ?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Herantis Pharma OYJ’s P/E ratio is -4.80.
What is the Price-to-Book ratio of Herantis Pharma OYJ?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Herantis Pharma OYJ P/B ratio is -923.6842.
What is the 50-day moving average of Herantis Pharma OYJ?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Herantis Pharma OYJ 50-day moving average is $3.51.
